22031-1-AP

antibody from Proteintech Group

Targeting: VIM

Provider product page for 22031-1-AP

Western blot

ELISA

Immunohistochemistry

Antibody data

Antibody Data
Antigen structure
References [46]
Comments [0]
Validations
Western blot [1]

Submit

Product number: 22031-1-AP - Provider product page
Provider: Proteintech Group
Proper citation: Proteintech Cat#22031-1-AP, RRID:AB_11182825
Product name: Vimentin antibody
Antibody type: Polyclonal
Description: Vimentin antibody (Cat. #22031-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
Reactivity: Human, Mouse, Rat
Host: Rabbit
Conjugate: Unconjugated
Isotype: IgG
Vial size: 20ul, 150ul

VIM protein structure - 22031-1-AP shown in red.

Submitted references Nobiletin and polydatin synergistically alleviate triple-negative breast cancer liver metastasis via suppressing ECM1a-mediated fatty acid biosynthesis.

Wang J, Liu WW, Huang QL, Ning HJ, Wang JY, Han XH
Acta pharmacologica Sinica 2026 Mar;47(3):735-749

ANO6 Confers Paclitaxel Resistance by Targeting Ferroptosis in Cervical Cancer.

Cao Y, Peng Y, Shen J
BioFactors (Oxford, England) 2026 Mar-Apr;52(2):e70070

WDR63 enhances the chondrogenic differentiation and regenerative potential of stem cell from apical papilla by facilitating vimentin function to promote mitochondrial fission.

Zhou J, Cao Y, Sun Z, Huang Y, Zhu M, Fan Z
Stem cell research & therapy 2026 Mar 8;17(1)

Biglycan knockdown improves Graves' orbitopathy (GO)-like features via inhibiting NF-kB and ERK signaling.

Chenzhao C, Zhu M, Zhang F, Xie B, Cao J, Xiong W, Tan Y
Journal of endocrinological investigation 2026 Mar 2;

Deficiency of NF-Erythroid 2-Related Factor 2 Exacerbates the Scar Through ERK Signaling Pathway.

Hao X, Sun M, Wang R, Chen H, Huang J, Luo J, Yu H, Li Y, Xing W, Li X, Hu L
Immunity, inflammation and disease 2026 Feb;14(2):e70361

VAMP7 governs ferroptosis suppression and cisplatin resistance in esophageal cancer: a dual-targeting therapeutic paradigm.

Zhu J, Xie M, Dai L, Yang Z, Xue W, Jiang Z, Zhou J
Cancer cell international 2026 Feb 3;26(1)

Psoralen Promotes Direct Chemical Reprogramming of Mouse Embryonic Fibroblasts into Osteoblast-like Cells.

Li W, Liu H, Wan X, Cheng D, Zhu R, Zhang Z
Pharmaceutics 2026 Feb 23;18(2)

INHBB promotes liver metastasis of colorectal cancer via regulation of TGF-β/Smad signaling, EMT and anoikis resistance.

Yang N, Dai D, Zhao J, Zhao H, Jiang H, Liu J, Liu F, Chen X
Tissue & cell 2026 Apr;99:103258

lncRNA DLGAP1-AS2 Modulates the TGF-β/Smad Signaling Pathway to Regulate Epithelial-Mesenchymal Transition in Renal Cell Carcinoma.

Cao H, Zhu J, Zhang L, Li L, Ma L, Xie C
Biochemical genetics 2026 Apr 11;

Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling.

Su L, Qiao C, Luo J, Zhu B, Liu Y
Scientific reports 2025 Sep 26;15(1):32986

LGI3 promotes the progression of TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB axis.

Liu J, Feng H, Xiong Z, Cao S, Cai T, Wei W, Tao W, Zhang X, Ma X, Li X
Oncogene 2025 Oct;44(39):3729-3740

Hypermethylation-mediated HNF4A silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell polarity and activating EMT signaling.

Li D, Zhou Z, Li X, Guo Q, Yuan L, Zhang X, Zhai L, Xia L, Leng W, Qin S
Cell death & disease 2025 Oct 6;16(1):688

EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial-mesenchymal phenotypes due to an inflammatory microenvironment.

Li D, Zhou Z, Hui Y, Yu H, Ren T, Zhai L, Li X, Yuan L, Xia L, Leng W, Qin S
Experimental & molecular medicine 2025 Nov;57(11):2440-2457

N-glycosylation stabilized TNFAIP6 promotes ovarian cancer metastasis by activating the PI3K-AKT signaling pathway.

Liu X, Ji D, Wen Z, Tang Q, Chen Y
Cellular signalling 2025 Nov;135:112013

Deciphering metastasis in pediatric Wilms' and rhabdoid tumors: IMPA2 as a key molecular player and promising therapeutic target.

Li S, Yan J, Zhang X, Xiao Z, Mu N, Sha G, Zhang W, Zhou Y, Wang Z, Zhang Y, Li L
Biochemical and biophysical research communications 2025 Nov 19;790:152875

GP73-dependent regulation of exosome biogenesis promotes colorectal cancer liver metastasis.

Huang L, Wei M, Li H, Yu M, Wan L, Zhao R, Gao Q, Sun L, Hou X, Mo Y, Huang Q, Zhen L, Yang X, Li J, Wang N, Zhang C, Jin H, Zhou L, Xu Y, Lin H, Zhang X, Li B, Han Y, Yuan J, Zhang R, Wu F, Zhong H, Wei C
Molecular cancer 2025 May 26;24(1):151

Single-cell and spatial transcriptome profiling reveal CTHRC1+ fibroblasts promote EMT through WNT5A signaling in colorectal cancer.

Lu Y, Chen Y, Wang Z, Shen H, Xu L, Huang C, Tong Y, Shao Y, Zhang H, Fu Z
Journal of translational medicine 2025 Mar 6;23(1):282

Charge-reversed small extracellular vesicles from human adipose-derived mesenchymal stromal cells attenuate renal fibrosis postacute kidney injury by inhibiting epithelial-mesenchymal transition progression in SD rat model.

Ping W, Xu X, Jiang Y, Yang R, Xu L
Cytotherapy 2025 Jun;27(6):753-765

Dermal papilla cells-conditioned medium attenuates oxidative stress-induced senescence via ferroptosis inhibition.

Ru Z, Wu Y, Qu Q, Miao Y, Zhu L, Hu Z
Scientific reports 2025 Jul 9;15(1):24789

The Ile35 Residue of the ALS-Associated Mutant SOD1 Plays a Crucial Role in the Intracellular Aggregation of the Molecule.

Asai Y, Yano K, Higashino T, Yoshihara D, Sakiyama H, Eguchi H, Fukushima K, Suzuki K, Fujiwara N
Molecular neurobiology 2025 Feb;62(2):2023-2038

CTHRC1 serves as an indicator in biliary atresia for evaluating the stage of liver fibrosis and predicting prognosis.

Ding Z, Zhang R, Zhu W, Lu Y, Zhu Z, Xie H, Tang W
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2025 Feb;57(2):385-393

A novel Cdc42-YAP-fibronectin signaling axis regulates ameloblast differentiation during early enamel formation.

Zhang J, Gao J, Zeng X, Wang Z, Chen C, Rong C, Li S, Cai L, Wang L, Zhang L, Tian Z
Biochimica et biophysica acta. Molecular basis of disease 2025 Feb;1871(2):167570

Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway.

Fan XP, Wang JR, Chen SY, Li XR, Cao JL, Wang HB, Ding LY, Che TJ, Yang L
Scientific reports 2025 Feb 8;15(1):4748

Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease.

Duan Q, Liu Z, Xing Y, Huang H, Zhu L, Liu J, He P, Ma G, Zhang Y, Nie K, Gao Y, Wang L
Journal of translational medicine 2025 Feb 5;23(1):161

Aspirin impedes non-small cell lung cancer development via fine-tuning the CD36 localization regulated by GPIHBP1.

Liu W, Qiao D, Chen J, Gao Y, Okuda K, Shimada Y, Yao L
Translational lung cancer research 2025 Feb 28;14(2):491-512

The loss of Spinster homolog 2 drives endothelial mesenchymal transition via SMS2-mediated disruption of sphingomyelin metabolism.

Qin JF, Li Y, Wang XD, Tu S, Zhu X, Yin K
Cellular and molecular biology (Noisy-le-Grand, France) 2025 Feb 2;71(1):135-141

SMYD4 promotes MYH9 ubiquitination through lysine monomethylation modification to inhibit breast cancer progression.

Yang JS, Cao JM, Sun R, Zhou XJ, Chen ZH, Liu BW, Liu XF, Yu Y, Wang X
Breast cancer research : BCR 2025 Feb 10;27(1):20

IMUP promotes fatty acid metabolism and lung cancer progression by regulating TGF-β/SMAD3 signaling pathway.

Wu S, Liu F, Yao X, Lei Y, Wang W
Tissue & cell 2025 Dec;97:103061

Single-cell sequencing reveals MCAM(+) MyCAFs as key pro-angiogenic cells interacting with endothelial cells in solid-type adenoid cystic carcinoma.

Yuan X, Liu Y, Zhang B, Fang Y, Meng L, Chen Z, Zhang H, Mo Y, Jiang W
Cancer cell international 2025 Dec 8;26(1):10

The SREBF2-ACOT7 axis promotes tumor progression and predicts prognosis in diffuse large b-cell lymphoma.

Wang H, Yao X, Wu S, Heng J, Cheng Y, Li L
Scientific reports 2025 Dec 7;15(1):43505

NAT10-mediated N4-acetylcytidine (ac4C) modification of PIK3R2 mRNA promotes malignant progression of glioblastoma.

Meng X, Dong T, Xu J, Tian K, Yang W, Liu Z, Qian Y, Liu D, Chen C, Bai J, Yong H, Wu X, Shen Z
Cell death & disease 2025 Dec 17;17(1):106

The LysoPS/GPR174 axis drives metastatic progression in esophageal squamous cell carcinoma through cAMP-PKA-CREB signaling activation.

Xiao R, Xu P, Li X, Shen F, Tao S, Zhu X, Cai Y, Feng Z, Liu Z, Xiao H, Ding F, Zhu M
Journal of translational medicine 2025 Apr 14;23(1):438

Pretreatment with Inflammatory Factors Altered the Secretome of Human Amniotic Epithelial Cells.

Cao W, Zhang Q, Huang Y, Zhang Q, Lai D
Tissue engineering. Part C, Methods 2024;30(6):255-267

PR/SET domain 1 targeting glutathione peroxidase 4 regulates chronic hepatitis B liver fibrosis through ferroptosis.

Wu W, Ke W, Shi W, Lin T, Lin S, Lin M, Ma H, Gao H
CytoJournal 2024;21:78

miR-34b-5p suppresses the epithelial-mesenchymal transition and metastasis in endometrial cancer AN3CA cells by targeting ZEB1.

Shi L, Yang D, Dong H, Zhang X, Yang C
International journal of clinical and experimental pathology 2024;17(4):137-150

A Model to Predict Prognosis of Renal Cell Clear Cell Carcinoma Based on 3 Angiogenesis-related Long Non-coding RNAs.

Chen G, Zhang T, Li F, Cui C, Huang Z, Gou X, Song Y, Li Y
Journal of Cancer 2024;15(11):3481-3494

CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.

Yu X, Li S, Ke S, Ye C, Wang Q, Wang H, Wang L
Journal of Cancer 2024;15(11):3242-3253

High glucose-induced NCAPD2 upregulation promotes malignant phenotypes and regulates EMT via the Wnt/β-catenin signaling pathway in HCC.

Mai Y, Liao C, Wang S, Zhou X, Meng L, Chen C, Qin Y, Deng G
American journal of cancer research 2024;14(4):1685-1711

SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production.

Yu Z, Liao H, Wu G, Liu Y, Zhang G, Xiao L, Yang S, Liu J, Yang G
The clinical respiratory journal 2024 Nov;18(11):e70033

ZNF652 exerts a tumor suppressor role in lung cancer by transcriptionally downregulating cyclin D3.

Xie C, Zhou X, Wu J, Chen W, Ren D, Zhong C, Meng Z, Shi Y, Zhu J
Cell death & disease 2024 Nov 5;15(11):792

Transcriptomics of tissue exosomes to investigate miR-195-5p's amelioration of endometrial fibrosis via the YAP-Smad7 pathway: an animal study.

Chen JM, Huang QY, Chen WH, Wu JX, Zheng LT, You HJ, Shi YC, Lin S, Shi QR
Journal of translational medicine 2024 Nov 21;22(1):1050

CLIC4 Is a New Biomarker for Glioma Prognosis.

Liu Z, Liu J, Chen Z, Zhu X, Ding R, Huang S, Xu H
Biomedicines 2024 Nov 11;12(11)

Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.

Yang X, Li F, Shi Y, Wu Y, Yang R, Liu X, Zhang Y, Zhang G, Ma M, Luo Z, Han X, Xie Y, Liu S
Acta biochimica et biophysica Sinica 2024 May 25;56(5):763-775

miR-1202 regulates BPH-1 cell proliferation, apoptosis, and epithelial-to-mesenchymal transition through targeting HMGCL.

Wang Z, Yin X, Yang P, Gong B, Liu H
Acta biochimica et biophysica Sinica 2024 May 25;56(5):675-687

Activation of ferritin light chain (FTL) by transcription factor salmonella pathogenicity island 1 modulates glycolysis to drive metastasis of ovarian cancer cells.

Li C, Yang Y, Lin Y, Lian Y, Pan D, Lin L, Li L
Expert review of anticancer therapy 2024 Dec;24(12):1271-1282

Fibrin-konjac glucomannan-black phosphorus hydrogel scaffolds loaded with nasal ectodermal mesenchymal stem cells accelerated alveolar bone regeneration.

Zou Y, Mei X, Wang X, Zhang X, Wang X, Xiang W, Lu N
BMC oral health 2024 Aug 2;24(1):878

No comments: Submit comment

Supportive validation

Submitted by: Proteintech Group (provider)
Main image
Experimental details: The Vimentin antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human Vimentin. This antibody recognizes human,mouse,rat antigen. The Vimentin antibody has been validated for the following applications: ELISA, WB analysis.
Appendix: 22031-1-AP.pdf

: Show more